Evidence map›Paper›PMID 36326727›Full record

ArticleInvestigative ophthalmology & visual science2022

Zfp503/Nlz2 Is Required for RPE Differentiation and Optic Fissure Closure.

Elangovan Boobalan, Amy H Thompson, Ramakrishna P Alur, David M McGaughey, Lijin Dong, Grace Shih, Emile R Vieta-Ferrer, Ighovie F Onojafe, Vijay K Kalaskar, Gavin Arno and 17 more

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 6 institutions in 3 countries.

Elangovan BoobalanPediatric, Developmental & Genetic Ophthalmology Section, Ophthalmic Genetics & Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Amy H ThompsonPediatric, Developmental & Genetic Ophthalmology Section, Ophthalmic Genetics & Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Ramakrishna P AlurPediatric, Developmental & Genetic Ophthalmology Section, Ophthalmic Genetics & Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
David M McGaugheyPediatric, Developmental & Genetic Ophthalmology Section, Ophthalmic Genetics & Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Lijin DongMouse Genetic Engineering Core, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Grace ShihPediatric, Developmental & Genetic Ophthalmology Section, Ophthalmic Genetics & Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Emile R Vieta-FerrerPediatric, Developmental & Genetic Ophthalmology Section, Ophthalmic Genetics & Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Ighovie F OnojafePediatric, Developmental & Genetic Ophthalmology Section, Ophthalmic Genetics & Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Vijay K KalaskarPediatric, Developmental & Genetic Ophthalmology Section, Ophthalmic Genetics & Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Gavin ArnoUniversity College London Institute of Ophthalmology, London, United Kingdom.
Andrew J LoteryFaculty of Medicine, University of Southampton, Southampton, United Kingdom.
Bin GuanOphthalmic Genetics Laboratory, Ophthalmic Genetics & Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Chelsea BenderOphthalmic Genetics Laboratory, Ophthalmic Genetics & Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Omar MemonOcular and Stem Cell Translational Research Section, Ophthalmic Genetics & Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Lauren BrinsterDivision of Veterinary Resources, Office of Research Services, National Institutes of Health, Bethesda, Maryland, United States.
Clement SoleilhavoupMRC Toxicology Unit, University of Cambridge, Leicester, United Kingdom.
Lia PanmanMRC Toxicology Unit, University of Cambridge, Leicester, United Kingdom.
Tudor C BadeaRetinal Circuit Development and Genetics Unit, Neurobiology, Neurodegeneration and Repair Laboratory, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Andrea MinellaDepartment of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, California, United States.
Antonio Jacobo LopezDepartment of Ophthalmology and Vision Science, School of Medicine, University of California-Davis, Davis, California, United States.
Sara M ThomasyDepartment of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, California, United States.
Ala MoshiriDepartment of Ophthalmology and Vision Science, School of Medicine, University of California-Davis, Davis, California, United States.
Delphine BlainPediatric, Developmental & Genetic Ophthalmology Section, Ophthalmic Genetics & Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Robert B HufnagelOphthalmic Genetics Laboratory, Ophthalmic Genetics & Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Tiziana CogliatiPediatric, Developmental & Genetic Ophthalmology Section, Ophthalmic Genetics & Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Kapil BhartiOcular and Stem Cell Translational Research Section, Ophthalmic Genetics & Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Brian P BrooksPediatric, Developmental & Genetic Ophthalmology Section, Ophthalmic Genetics & Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
National Eye Institute · USNational Institutes of Health · USUniversity of California, Davis · USUniversity of Cambridge · GBUniversity College London · GBUniversity of Southampton · GB

Funding

The Role of ARAP1 in Retinal Photoreceptor HomeostasisK08EY027463 · NEI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MOSHIRI, ALA · 2017 to 2021
$1.0M
Cancer Research UKMedical Research Council MC_UP_1203/2Medical Research Council MC_UU_00025/1NEI NIH HHS K08 EY027463Wellcome Trust
6 · The paper itself

Abstract

Purpose: Uveal coloboma is a congenital eye malformation caused by failure of the optic fissure to close in early human development. Despite significant progress in identifying genes whose regulation is important for executing this closure, mutations are detected in a minority of cases using known gene panels, implying additional genetic complexity. We have previously shown knockdown of znf503 (the ortholog of mouse Zfp503) in zebrafish causes coloboma. Here we characterize Zfp503 knockout (KO) mice and evaluate transcriptomic profiling of mutant versus wild-type (WT) retinal pigment epithelium (RPE)/choroid. Methods: Zfp503 KO mice were generated by gene targeting using homologous recombination. Embryos were characterized grossly and histologically. Patterns and level of developmentally relevant proteins/genes were examined with immunostaining/in situ hybridization. The transcriptomic profile of E11.5 KO RPE/choroid was compared to that of WT. Results: Zfp503 is dynamically expressed in developing mouse eyes, and loss of its expression results in uveal coloboma. KO embryos exhibit altered mRNA levels and expression patterns of several key transcription factors involved in eye development, including Otx2, Mitf, Pax6, Pax2, Vax1, and Vax2, resulting in a failure to maintain the presumptive RPE, as evidenced by reduced melanin pigmentation and its differentiation into a neural retina-like lineage. Comparison of RNA sequencing data from WT and KO E11.5 embryos demonstrated reduced expression of melanin-related genes and significant overlap with genes known to be dynamically regulated at the optic fissure. Conclusions: These results demonstrate a critical role of Zfp503 in maintaining RPE fate and optic fissure closure.

Indexed as

ColobomaNeuropeptidesAnimalsGene Expression Regulation, DevelopmentalHomeodomain ProteinsHumansIntracellular Signaling Peptides and ProteinsMelaninsMiceMice, KnockoutNerve Tissue ProteinsRetinaRetinal Pigment EpitheliumZebrafishHomeodomain ProteinsIntracellular Signaling Peptides and ProteinsMelaninsNerve Tissue ProteinsNeuropeptidesVax1 protein, mouseVAX2 protein, humanZfp503 protein, mouse

Identifiers

PMID36326727
PMCPMC9645360
OpenAlexW4308026182

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.